Review, Systematic [inpr]
economic evaluation [ocac]
Statins [orch, phsu]
Prevention [topp]
coronary [bpoc]
Events [evnt]
objectives [inpr]
To [qlco]
Evaluate [ftcn]
Clinical [qlco]
Effectiveness [qlco]
Cost Effectiveness [qnco]
Statins [orch, phsu]
Primary [qlco]
Secondary Prevention [topp]
cardiovascular events [fndg]
Adults [aggp]
coronary heart disease [dsyn]
Data Sources [qnco]
Database, Electronic [inpr]
Searched [acty]
Review [inpr]
Methods [inpr]
Review [inpr]
To [qlco]
Evaluate [ftcn]
Literature [inpr]
Relate [orch]
Clinical [qlco]
Cost Effectiveness [qnco]
Statins [orch, phsu]
Primary [qlco]
Secondary Prevention [topp]
coronary heart disease [dsyn]
Cardiovascular disease [dsyn]
Model [inpr]
To [qlco]
Costs [qnco]
Health Outcomes [inpr]
Associated [qlco]
Statin [orch, phsu]
treatment [ftcn]
Using [ftcn]
NHS [cgab, dsyn]
Result [ftcn]
One [qnco]
studies [lbpr]
Identified [qlco]
Compared [acty]
Statin [orch, phsu]
placebo [topp]
Statin [orch, phsu]
Reported [inpr]
Clinical [qlco]
Outcome [ftcn]
Meta-Analysis [inpr]
Available [ftcn]
Data [idcn]
placebo controlled study [inpr, resa]
Patients [podg]
Cardiovascular disease [dsyn]
Statin [orch, phsu]
therapy [ftcn]
Associated [qlco]
Reduced [qlco]
Relative Risk [qnco]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
coronary heart disease [dsyn]
Mortality [qnco]
Fatal [qlco]
Myocardial Infarction [dsyn]
Not [ftcn]
Fatal [qlco]
Stroke [dsyn]
Associated [qlco]
Reduced [qlco]
Relative Risk [qnco]
Morbidity [qnco]
Non [ftcn]
Fatal [qlco]
Stroke [dsyn]
Non [ftcn]
Fatal [qlco]
Myocardial Infarction [dsyn]
Transient Ischemic Attack [dsyn]
Angina, Unstable [dsyn]
coronary revascularisation [topp]
Possible [qlco]
Evidence [ftcn]
Available [ftcn]
placebo-controlled [resa]
Trial [resa]
To [qlco]
differentiate [qlco]
Clinical [qlco]
Efficacy [qlco]
atorvastatin [orch, phsu]
fluvastatin [orch, phsu]
Pravastatin [orch, phsu]
Simvastatin [orch, phsu]
Evidence [ftcn]
Direct [qlco]
Comparison [acty]
Statins [orch, phsu]
Suggest [idcn]
atorvastatin [orch, phsu]
More [ftcn]
effective [qlco]
Pravastatin [orch, phsu]
Patients [podg]
Symptomatic [ftcn]
coronary heart disease [dsyn]
Limited [ftcn]
Evidence [ftcn]
Effectiveness [qlco]
Statins [orch, phsu]
Different [qlco]
subgroups [virs]
Statins [orch, phsu]
considered [idcn]
To [qlco]
Well [qlco]
To [qlco]
Good [qlco]
Safety [hcpp]
Profile [lbpr]
This [euka]
View [spco]
Supported [cnce]
Evidence [ftcn]
Trial [resa]
included [ftcn]
Review [inpr]
surveillance [ftcn]
Data [idcn]
increases [ftcn]
Creatine Kinase [aapp, enzy]
Myopathy [dsyn]
Reported [inpr]
Rhabdomyolysis [patf]
Hepatotoxicity [inpo]
Rare [tmco]
Patients [podg]
Receive [qlco]
Lipid-lowering therapy [topp]
Long [qlco]
Long-term [tmco]
Safety [hcpp]
Timespan [tmco]
Unknown [qlco]
Secondary Prevention [topp]
coronary heart disease [dsyn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Increase [ftcn]
Age [orga]
pound [qnco]
pound [qnco]
Year, Quality-Adjusted Life [tmco]
Age [orga]
Sensitivity [qnco]
Analysis [lbpr]
Show [inpr]
Result [ftcn]
Robust [qlco]
Primary Prevention [topp]
coronary heart disease [dsyn]
Variation [qlco]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Age [orga]
Risk [qlco]
Average [qnco]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
weighted [orga]
Risk [qlco]
Range [qnco]
pound [qnco]
pound [qnco]
Men [popg]
pound [qnco]
pound [qnco]
Women [popg]
Result [ftcn]
Sensitive [ftcn]
Cost [qnco]
Statins [orch, phsu]
discount rates [qnco]
Modeling [inpr, resa]
Time frame [tmco]
Cardiovascular disease [dsyn]
Analysis [lbpr]
Take [hlca]
account [idcn]
Benefits [qnco]
Statins [orch, phsu]
reductions [npop]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
Events [evnt]
Average [qnco]
ICER [gngm]
weighted [orga]
Risk [qlco]
Level [qlco]
pound [qnco]
Coronary heart disease risk [inpr]
Level [qlco]
limitations [ftcn]
Analysis [lbpr]
Requirement [ftcn]
Well [qlco]
Time frame [tmco]
Trial [resa]
To [qlco]
Effectiveness [qlco]
Result [ftcn]
High Risk Populations [popg]
Primary Prevention [topp]
treatment [ftcn]
Population [qnco]
Low Risk [fndg]
Result [ftcn]
Lower [spco]
Age [orga]
Bands [medd]
Lower [spco]
Risks [qlco]
Uncertainty [idcn]
Need [qlco]
To [qlco]
treated [topp]
Conclusions [idcn]
Evidence [ftcn]
Suggest [idcn]
Statin [orch, phsu]
therapy [ftcn]
Associated [qlco]
statistically significant [qnco]
reduction [npop]
Risk [qlco]
Primary [qlco]
secondary [neop]
cardiovascular events [fndg]
Confidence Intervals [qnco]
Outcome [ftcn]
Prevention [topp]
Category [inpr]
overlap [topp]
Not [ftcn]
Possible [qlco]
differentiate [qlco]
Relative Risk [qnco]
Effectiveness [qlco]
Statins [orch, phsu]
Primary [qlco]
Secondary Prevention [topp]
absolute risk [qnco]
coronary heart disease [dsyn]
Death [orgf]
Non [ftcn]
Fatal [qlco]
Myocardial Infarction [dsyn]
High [qlco]
Needed [qlco]
To [qlco]
TREAT [ftcn]
To [qlco]
Event [evnt]
Lower [spco]
secondary [neop]
Primary Prevention [topp]
Result [ftcn]
Limited [ftcn]
EXCLUSION [ftcn]
studies [lbpr]
Patients [podg]
intolerant [ftcn]
Known [qlco]
To [qlco]
Unresponsive [ftcn]
Statins [orch, phsu]
Not [ftcn]
Compliant [qlco]
Study [mnob]
Medication [phsu]
placebo [topp]
RUN-IN [tmco]
Phase [tmco]
Treatment Effect [fndg]
Reduced [qlco]
Statins [orch, phsu]
Population [qnco]
Result [ftcn]
Economic [ocdi]
Modeling [inpr, resa]
Show [inpr]
Statin [orch, phsu]
therapy [ftcn]
Secondary Prevention [topp]
Likely [qlco]
considered [idcn]
Cost Effectiveness [qnco]
Primary Prevention [topp]
Cost Effectiveness [qnco]
Ratios [qnco]
Dependent [qlco]
Level [qlco]
Coronary heart disease risk [inpr]
Age [orga]
Result [ftcn]
Cardiovascular disease [dsyn]
Analysis [lbpr]
Support [medd]
More [ftcn]
aggressive [mobd]
treatment [ftcn]
Recommendation [idcn]
Issue [fndg]
Recent [tmco]
Guidelines [inpr]
Evidence [ftcn]
Clinical Endpoint [clna]
rosuvastatin [orch, phsu]
On [ftcn]
Trial [resa]
Potential [qlco]
Targeting [ftcn]
Statins [orch, phsu]
Low Risk [fndg]
Population [qnco]
Associated [qlco]
Major [qlco]
uncertainties [idcn]
Likely [qlco]
Uptake [phsf]
Long-term [tmco]
Compliance [qnco]
Medication [phsu]
Asymptomatic [fndg]
Young [tmco]
Patients [podg]
Targeting [ftcn]
Assessment [hlca]
Monitoring [hlca]
Low Risk [fndg]
Patients [podg]
Primary Care [hlca]
Major [qlco]
Resource [idcn]
NHS [cgab, dsyn]
Further [spco]
